PTCB Updated PTCE Exam Questions and Answers by iyla

Risk Evaluation and Mitigation Strategies (REMS)areFDA-required programsto ensure that thebenefits of certain medications outweigh their risks. REMS programsrestrict prescribing, dispensing, and monitoringdue to the potential for serious side effects or misuse.

Suboxoneis used foropioid dependenceand containsbuprenorphine, apartial opioid agonist, which can causeaddiction, misuse, and respiratory depressionif used improperly.

REMS Requirements for Suboxone:

Prescriber Certification:Only specially certified providers can prescribe Suboxone.

Patient Education:Patients must be informed about the risks of misuse, overdose, and dependence.

Limited Dispensing:Pharmacists must ensure prescriptions meet REMS criteria before dispensing.

A. Xarelto (Rivaroxaban).→ Incorrect. While Xarelto is an anticoagulant, it isnot under REMS.

C. Warfarin.→ Incorrect. Warfarin requires monitoring butdoes not have a REMS program.

D. Haloperidol.→ Incorrect. Haloperidol is an antipsychotic, but itdoes not have a REMS program.

FDA REMS Program List (www.accessdata.fda.gov).

Suboxone REMS Guidelines (www.suboxonerems.com).

PTCB PTCE Exam Content Outline – REMS and Medication Safety.

Mosby’s Pharmacy Technician: Principles and Practice – REMS Regulations.

Why Is Suboxone (Buprenorphine/Naloxone) Under REMS?Why the Other Answer Choices Are Incorrect:Pharmacy Technician References:

Amlodipine(10 mg) anddiltiazem(30 mg) are bothcalcium channel blockers (CCBs)used to treat hypertension and angina.

When a patient is prescribed two medications from the same therapeutic class, the pharmacy's prescription processing system may flag this as"therapeutic duplication."

This alert is meant toprevent potential adverse effectssuch as excessive lowering of blood pressure or heart rate.

A. Prior authorization required→ Not applicable unless the insurance requires special approval before covering the drug.

C. NDC not covered→ Would appear if the specific drug product (based on its National Drug Code) is not covered by insurance, but this scenario relates to duplication, not coverage.

D. Refill too soon→ This applies to refilling a medication before the allowed time frame, but the scenario describes a new prescription.

PTCB PTCE Exam Content Outline – Drug Interactions and Therapeutic Duplication

Lexicomp and Micromedex Drug Databases– Reference sources for drug classifications.

ISMP Guidelines on Preventing Therapeutic Duplication Errors

Why Other Answers Are Incorrect?Pharmacy Technician References:

Oxaprozinis anonsteroidal anti-inflammatory drug (NSAID)used to treat arthritis. It is listed on theISMP (Institute for Safe Medication Practices) List of Confused Drug Namesdue to its similarity toTopamax (topiramate), an anticonvulsant used for epilepsy and migraine prevention. The confusion arises because both drug nameslook and sound similar, which can lead to dispensing errors.

A. Tobradex→ Incorrect. Tobradex is anantibiotic/steroid ophthalmic medicationand is not confused with oxaprozin.

C. Tradjenta→ Incorrect. Tradjenta (linagliptin) is aDPP-4 inhibitor for diabetesand is not commonly confused with oxaprozin.

D. Trileptal→ Incorrect. Trileptal (oxcarbazepine) is ananticonvulsantbut is not on the ISMP Confused Drug List with oxaprozin.

Incorrect Answer Choices:Pharmacy Technician References:

PTCB PTCE Exam Content Outline (Error Prevention and Look-Alike/Sound-Alike (LASA) Drugs)

Institute for Safe Medication Practices (ISMP) List of Confused Drug Names

FDA Drug Safety Communications

Mosby’s Pharmacy Technician Exam Review

Comprehensive and Detailed Step-by-Step Explanation:

ACE inhibitors (Angiotensin-Converting Enzyme inhibitors)are medications thatrelax blood vesselsandlower blood pressure. Drugs in this class typically end in "-pril" (e.g.,Lisinopril, Enalapril, Ramipril).

????Explanation of Answer Choices:✅C. ACE inhibitors→Correct.These lowerblood pressure and reduce strain on the heart.❌A. Beta blockers→ Incorrect.End in "-olol" (e.g., Metoprolol, Propranolol), reduce heart rate.❌B. Calcium channel blockers→ Incorrect.End in "-dipine" (e.g., Amlodipine, Nifedipine), lower blood pressure differently.❌D. Statins→ Incorrect.End in "-statin" (e.g., Atorvastatin, Simvastatin), used for cholesterol, not blood pressure.

????Reference:

American Heart Association (AHA) Guidelines

FDA Drug Classification Database